Current concepts in the management of tuberculosis

Mayo Clinic Proceedings

Volumn 86, Issue 4, 2011, Pages 348-361

  Sia, Irene G ^a   Wieland, Mark L ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMINOSALICYLIC ACID; ANTIRETROVIRUS AGENT; CAPREOMYCIN; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; GAMMA INTERFERON; GATIFLOXACIN; ISONIAZID; KANAMYCIN; LEVOFLOXACIN; MOXIFLOXACIN; PROTIONAMIDE; PYRAZINAMIDE; PYRIDOXINE; QUINOLONE DERIVATIVE; RIFABUTIN; RIFAMPICIN; RIFAPENTINE; STREPTOMYCIN; THIOAMIDE;

ACID FAST BACTERIUM; ALOPECIA; ARTHRALGIA; BACTERIAL CLEARANCE; BLOOD CLOTTING DISORDER; BODY FLUID DISCOLORATION; CENTRAL NERVOUS SYSTEM TUBERCULOSIS; CIRCUMORAL PARESTHESIA; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONFERENCE PAPER; CYTOKINE RELEASE; DEMOGRAPHY; DEPRESSION; DERMATITIS; DIRECTLY OBSERVED THERAPY; DISEASE TRANSMISSION; DIZZINESS; DRUG CONTRAINDICATION; DRUG DOSE REGIMEN; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG INDUCED HEADACHE; EXTRAPULMONARY TUBERCULOSIS; FEVER; GASTROINTESTINAL SYMPTOM; GEOGRAPHIC DISTRIBUTION; GOUT; GYNECOMASTIA; HEALTH CARE PERSONNEL; HEPATITIS; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERURICEMIA; HYPOTHYROIDISM; IMPOTENCE; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; INSOMNIA; LABORATORY DIAGNOSIS; LATENT TUBERCULOSIS; LIVER TOXICITY; LUNG TUBERCULOSIS; MALABSORPTION; METALLIC TASTE EFFECT; MILIARY TUBERCULOSIS; MIXED INFECTION; MYCOBACTERIUM TUBERCULOSIS; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; NIGHT SWEAT; NUCLEIC ACID AMPLIFICATION; OPTIC NEURITIS; OTOTOXICITY; PARADOXICAL DRUG REACTION; PERIPHERAL NEURITIS; PERIPHERAL NEUROPATHY; PHOTOSENSITIVITY; POSTPRIMARY TUBERCULOSIS; PRACTICE GUIDELINE; PREGNANCY; PRIMARY HEALTH CARE; PRIMARY TUBERCULOSIS; PRURITUS; PSYCHOSIS; PUBLIC HEALTH PROBLEM; QT PROLONGATION; RISK REDUCTION; SEIZURE; SOCIOECONOMICS; SPUTUM CULTURE; SPUTUM SMEAR; TREATMENT DURATION; TREMOR; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOUS LYMPHADENITIS; TUBERCULOUS OSTEOMYELITIS; TUBERCULOUS PERICARDITIS; TUBERCULOUS PERITONITIS; TUBERCULOUS PLEURISY; UVEITIS; WEAKNESS; WEIGHT REDUCTION;

EID: 79953297274     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/mcp.2010.0820     Document Type: Conference Paper

References (115)

1. Spence DP, Hotchkiss J, Williams CS, Davies PD. Tuberculosis and poverty. BMJ. 1993;307:759-761. (Pubitemid 23279319)
2. Lonnroth K, Castro KG, Chakaya JM, et al. Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet. 2010;375:1814-1829.
3. Jensen PA, Lambert LA, Iademarco MF, Ridzon R. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep. 2005;54(RR-17):1-141.
4. Lonnroth K, Raviglione M. Global epidemiology of tuberculosis: prospects for control. Semin Respir Crit Care Med. 2008;29:481-491.
5. World Health Organization. Global Tuberculosis Control: Epidemiology, Strategy, Financing: WHO Report 2009. Geneva, Switzerland: World Health Organization; 2009.
6. World Health Organization. Global Tuberculosis Control: A Short Update to the 2009 Report. Geneva, Switzerland: World Health Organization; 2009.
7. World Health Organization. Multidrug and Extensively Drug-Resistant TB (M/XDR-TB): 2010 Global Report on Surveillance and Response. Geneva, Switzerland: World Health Organization; 2010.
8. Centers for Disease Control and Prevention (CDC). Reported Tuberculosis in the United States, 2009. Atlanta, GA: US Department of Health and Human Services, CDC; 2010. http://www.cdc.gov/tb/statistics/reports/2009/pdf/ report2009.pdf. Accessed February 22, 2011.
9. Geng E, Kreiswirth B, Driver C, et al. Changes in the transmission of tuberculosis in New York City from 1990 to 1999. N Engl J Med. 2002;346:1453-1458.
10. Cain KP, Benoit SR, Winston CA, Mac Kenzie WR. Tuberculosis among foreign-born persons in the United States. JAMA. 2008;300:405-412. (Pubitemid 352040252)
11. Zumla A. The white plague returns to London-with a vengeance. Lancet. 2011;377:10-11.
12. Loudon RG, Spohn SK. Cough frequency and infectivity in patients with pulmonary tuberculosis. Am Rev Respir Dis. 1969;99:109-111.
13. Tostmann A, Kik SV, Kalisvaart NA, et al. Tuberculosis transmission by patients with smear-negative pulmonary tuberculosis in a large cohort in the Netherlands. Clin Infect Dis. 2008;47:1135-1142.
14. Poulsen A. Some clinical features of tuberculosis; 1: incubation period. Acta Tuberc Pneumol Scand. 1950;24(3-4):311-346.
15. Poulsen A. Some clinical features of tuberculosis [concl]. Acta Tuberc Pneumol Scand. 1957;33(1-2):37-92.
16. Krysl J, Korzeniewska-Kosela M, Muller NL, FitzGerald JM. Radiologic features of pulmonary tuberculosis: an assessment of 188 cases. Can Assoc Radiol J. 1994;45:101-107. (Pubitemid 24162524)
17. Lee KS, Song KS, Lim TH, Kim PN, Kim IY, Lee BH. Adult-onset pulmonary tuberculosis: findings on chest radiographs and CT scans. AJR Am J Roentgenol. 1993;160:753-758.
18. Im JG, Itoh H, Shim YS, et al. Pulmonary tuberculosis: CT findings- early active disease and sequential change with antituberculous therapy. Radiology. 1993;186:653-660. (Pubitemid 23073501)
19. Marciniuk DD, McNab BD, Martin WT, Hoeppner VH. Detection of pulmonary tuberculosis in patients with a normal chest radiograph. Chest. 1999;115:445-452. (Pubitemid 29083055)
20. Pepper T, Joseph P, Mwenya C, et al. Normal chest radiography in pulmonary tuberculosis: implications for obtaining respiratory specimen cultures. Int J Tuberc Lung Dis. 2008;12:397-403. (Pubitemid 351507252)
21. Greenberg SD, Frager D, Suster B, Walker S, Stavropoulos C, Rothpearl A. Active pulmonary tuberculosis in patients with AIDS: spectrum of radiographic findings (including a normal appearance). Radiology. 1994;193:115-119. (Pubitemid 24298009)
22. Rikimaru T. Endobronchial tuberculosis. Expert Rev Anti Infect Ther. 2004;2:245-251. (Pubitemid 38735768)
23. Lee JH, Park SS, Lee DH, Shin DH, Yang SC, Yoo BM. Endobronchial tuberculosis: clinical and bronchoscopic features in 121 cases. Chest. 1992;102:990-994.
24. Van den Brande PM, Van de Mierop F, Verbeken EK, Demedts M. Clinical spectrum of endobronchial tuberculosis in elderly patients. Arch Intern Med. 1990;150:2105-2108. (Pubitemid 20348361)
25. Rikimaru T, Kinosita M, Yano H, et al. Diagnostic features and therapeutic outcome of erosive and ulcerous endobronchial tuberculosis. Int J Tuberc Lung Dis. 1998;2:558-562. (Pubitemid 28320063)
26. Chung HS, Lee JH. Bronchoscopic assessment of the evolution of endobronchial tuberculosis. Chest. 2000;117:385-392. (Pubitemid 30111587)
27. Peto HM, Pratt RH, Harrington TA, LoBue PA, Armstrong LR. Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006. Clin Infect Dis. 2009;49:1350-1357.
28. Raviglione MC, Narain JP, Kochi A. HIV-associated tuberculosis in developing countries: clinical features, diagnosis, and treatment. Bull World Health Organ. 1992;70:515-526.
29. Haas DW, Des Prez RM. Tuberculosis and acquired immunodeficiency syndrome: a historical perspective on recent developments. Am J Med. 1994;96:439-450. (Pubitemid 24156731)
30. Jones BE, Young SM, Antoniskis D, Davidson PT, Kramer F, Barnes PF. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis. 1993;148:1292-1297.
31. te Beek LA, van der Werf MJ, Richter C, Borgdorff MW. Extrapulmonary tuberculosis by nationality, The Netherlands, 1993-2001. Emerg Infect Dis. 2006;12:1375-1382.
32. Kempainen R, Nelson K, Williams DN, Hedemark L. Mycobacterium tuberculosis disease in Somali immigrants in Minnesota. Chest. 2001;119:176-180. (Pubitemid 32150564)
33. Rieder HL, Snider DE Jr, Cauthen GM. Extrapulmonary tuberculosis in the United States. Am Rev Respir Dis. 1990;141:347-351. (Pubitemid 20068872)
34. Thompson MM, Underwood MJ, Sayers RD, Dookeran KA, Bell PR. Peripheral tuberculous lymphadenopathy: a review of 67 cases. Br J Surg. 1992;79:763-764.
35. Geldmacher H, Taube C, Kroeger C, Magnussen H, Kirsten DK. Assessment of lymph node tuberculosis in northern Germany: a clinical review. Chest. 2002;121:1177-1182. (Pubitemid 34280440)
36. Dandapat MC, Mishra BM, Dash SP, Kar PK. Peripheral lymph node tuberculosis: a review of 80 cases. Br J Surg. 1990;77:911-912. (Pubitemid 20249702)
37. Jones PG, Campbell PE. Tuberculous lymphadenitis in childhood: the significance of anonymous mycobacteria. Br J Surg. 1962;50:302-314.
38. Ellison E, Lapuerta P, Martin SE. Fine needle aspiration diagnosis of mycobacterial lymphadenitis: Sensitivity and predictive value in the United States. Acta Cytol. 1999;43:153-157. (Pubitemid 29144707)
39. Lee KC, Tami TA, Lalwani AK, Schecter G. Contemporary management of cervical tuberculosis. Laryngoscope. 1992;102:60-64.
40. Baumann MH, Nolan R, Petrini M, Lee YC, Light RW, Schneider E. Pleural tuberculosis in the United States: incidence and drug resistance. Chest. 2007;131:1125-1132. (Pubitemid 46608716)
41. Berger HW, Mejia E. Tuberculous pleurisy. Chest. 1973;63:88-92.
42. Valdes L, Alvarez D, San Jose E, et al. Tuberculous pleurisy: a study of 254 patients. Arch Intern Med. 1998;158:2017-2021. (Pubitemid 28465626)
43. Gopi A, Madhavan SM, Sharma SK, Sahn SA. Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest. 2007;131:880-889.
44. Phypers M, Harris T, Power C. CNS tuberculosis: a longitudinal analysis of epidemiological and clinical features. Int J Tuberc Lung Dis. 2006;10:99-103. (Pubitemid 43266285)
45. Sutlas PN, Unal A, Forta H, Senol S, Kirbas D. Tuberculous meningitis in adults: review of 61 cases. Infection. 2003;31:387-391. (Pubitemid 38005368)
46. Kent SJ, Crowe SM, Yung A, Lucas CR, Mijch AM. Tuberculous meningitis: a 30-year review. Clin Infect Dis. 1993;17:987-994. (Pubitemid 23358742)
47. Hinman AR. Tuberculous meningitis at Cleveland Metropolitan General Hospital 1959 to 1963. Am Rev Respir Dis. 1967;95:670-673.
48. al Karawi MA, Mohamed AE, Yasawy MI, et al. Protean manifestation of gastrointestinal tuberculosis: report on 130 patients. J Clin Gastroenterol. 1995;20:225-232.
49. Sheldon CD, Probert CS, Cock H, et al. Incidence of abdominal tuberculosis in Bangladeshi migrants in east London. Tuber Lung Dis. 1993;74:12-15. (Pubitemid 23080928)
50. Aguado JM, Pons F, Casafont F, San Miguel G, Valle R. Tuberculous peritonitis: a study comparing cirrhotic and noncirrhotic patients. J Clin Gastroenterol. 1990;12:550-554. (Pubitemid 20303418)
51. Shakil AO, Korula J, Kanel GC, Murray NG, Reynolds TB. Diagnostic features of tuberculous peritonitis in the absence and presence of chronic liver disease: a case control study. Am J Med. 1996;100:179-185. (Pubitemid 26062512)
52. Sanai FM, Bzeizi KI. Systematic review: tuberculous peritonitis- presenting features, diagnostic strategies and treatment. Aliment Pharmacol Ther. 2005;22:685-700. (Pubitemid 41475330)
53. Bilgin T, Karabay A, Dolar E, Develioglu OH. Peritoneal tuberculosis with pelvic abdominal mass, ascites and elevated CA 125 mimicking advanced ovarian carcinoma: a series of 10 cases. Int J Gynecol Cancer. 2001;11:290-294. (Pubitemid 32751397)
54. Rodriguez E, Pombo F. Peritoneal tuberculosis versus peritoneal carcinomatosis: distinction based on CT findings. J Comput Assist Tomogr. 1996;20:269-272. (Pubitemid 26108713)
55. Jain S, Sharma N, Varma S, Rajwanshi A, Verma JS, Sharma BK. Profile of cardiac tamponade in the medical emergency ward of a North Indian hospital. Can J Cardiol. 1999;15:671-675. (Pubitemid 29335797)
56. Reuter H, Burgess LJ, Doubell AF. Epidemiology of pericardial effusions at a large academic hospital in South Africa. Epidemiol Infect. 2005;133:393-399. (Pubitemid 40867675)
57. Cameron J, Oesterle SN, Baldwin JC, Hancock EW. The etiologic spectrum of constrictive pericarditis. Am Heart J. 1987;113:354-360. (Pubitemid 17011295)
58. Mayosi BM, Wiysonge CS, Ntsekhe M, et al. Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: the Investigation of the Management of Pericarditis in Africa (IMPI Africa) registry. BMC Infect Dis. 2006;6:2.
59. Fowler NO, Manitsas GT. Infectious pericarditis. Prog Cardiovasc Dis. 1973;16:323-336.
60. Mehta JB, Dutt A, Harvill L, Mathews KM. Epidemiology of extrapulmonary tuberculosis: a comparative analysis with pre-AIDS era. Chest. 1991;99:1134-1138.
61. Hodgson SP, Ormerod LP. Ten-year experience of bone and joint tuberculosis in Blackburn 1978-1987. J R Coll Surg Edinb. 1990;35:259-262.
62. Mondal A. Cytological diagnosis of vertebral tuberculosis with fineneedle aspiration biopsy. J Bone Joint Surg Am. 1994;76:181-184. (Pubitemid 24116348)
63. Sharma SK, Mohan A, Sharma A, Mitra DK. Miliary tuberculosis: new insights into an old disease. Lancet Infect Dis. 2005;5:415-430. (Pubitemid 40840733)
64. Kim JH, Langston AA, Gallis HA. Miliary tuberculosis: epidemiology, clinical manifestations, diagnosis, and outcome. Rev Infect Dis. 1990;12:583-590. (Pubitemid 20223407)
65. Ahuja SS, Ahuja SK, Phelps KR, Thelmo W, Hill AR. Hemodynamic confirmation of septic shock in disseminated tuberculosis. Crit Care Med. 1992; 20:901-903.
66. Gachot B, Wolff M, Clair B, Regnier B. Severe tuberculosis in patients with human immunodeficiency virus infection. Intensive Care Med. 1990;16:491-493.
67. Piqueras AR, Marruecos L, Artigas A, Rodriguez C. Miliary tuberculosis and adult respiratory distress syndrome. Intensive Care Med. 1987;13:175-182. (Pubitemid 17055221)
68. American Thoracic Society; Centers for Disease Control and Prevention (CDC); Infectious Diseases Society of America. Treatment of tuberculosis [published correction appears in MMWR Recomm Rep. 2005;53(51):1203. Dosage error in article text]. MMWR Recomm Rep. 2003;52(RR-11):1-77.
69. American Thoracic Society. Diagnostic standards and classification of tuberculosis in adults and children.. Am J Respir Crit Care Med. 2000;161(4, pt 1):1376-1395.
70. Shinnick TM, Good RC. Diagnostic mycobacteriology laboratory practices. Clin Infect Dis. 1995;21(2):291-299.
71. Francis J. Curry National Tuberculosis Center. Sputum induction. In: Tuberculosis Infection Control: A Practical Manual for Preventing TB. San Francisco, CA: University of California; 2007:73-86. http://www. nationaltbcenter.edu/TB-IC/. Acessed February 22, 2011.
72. Centers for Disease Control and Prevention (CDC). Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. MMWR Morb Mortal Wkly Rep. 2009;58(1):7-10.
73. Mack U, Migliori G, Sester M, et al; TBNET. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J. 2009;33(5):956-973.
74. Moreno S, Blazquez R, Novoa A, et al. The effect of BCG vaccination on tuberculin reactivity and the booster effect among hospital employees. Arch Intern Med. 2001;161:1760-1765. (Pubitemid 32679551)
75. Menzies R, Vissandjee B, Amyot D. Factors associated with tuberculin reactivity among the foreign-born in Montreal. Am Rev Respir Dis. 1992;146:752-756.
76. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep. 2000;49(RR-6):1-51.
77. Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin Infect Dis. 1993;17:968-975. (Pubitemid 23358739)
78. Menzies D. Interpretation of repeated tuberculin tests: boosting, conversion, and reversion. Am J Respir Crit Care Med. 1999;159:15-21. (Pubitemid 29036497)
79. Menzies R, Vissandjee B, Rocher I, St Germain Y. The booster effect in two-step tuberculin testing among young adults in Montreal. Ann Intern Med. 1994;120:190-198.
80. Centers for Disease Control and Prevention (CDC). Core Curriculum on Tuberculosis: What the Clinician Should Know. 4th ed. Atlanta, GA: Centers for Disease Control and Prevention; 2000.
81. Blower SM, McLean AR, Porco TC, et al. The intrinsic transmission dynamics of tuberculosis epidemics. Nat Med. 1995;1(8):815-821.
82. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med. 2007;146:340-354. (Pubitemid 351650594)
83. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K. Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep. 2010;59:1-25.
84. Laraque F, Griggs A, Slopen M, Munsiff SS. Performance of nucleic acid amplification tests for diagnosis of tuberculosis in a large urban setting. Clin Infect Dis. 2009;49:46-54.
85. Campos M, Quartin A, Mendes E, et al. Feasibility of shortening respiratory isolation with a single sputum nucleic acid amplification test. Am J Respir Crit Care Med. 2008;178:300-305.
86. Catanzaro A, Perry S, Clarridge JE, et al. The role of clinical suspicion in evaluating a new diagnostic test for active tuberculosis: results of a multicenter prospective trial. JAMA. 2000;283:639-645. (Pubitemid 30069180)
87. Moore DF, Guzman JA, Mikhail LT. Reduction in turnaround time for laboratory diagnosis of pulmonary tuberculosis by routine use of a nucleic acid amplification test. Diagn Microbiol Infect Dis. 2005;52:247-254. (Pubitemid 41133551)
88. Guerra RL, Hooper NM, Baker JF, et al. Use of the amplified Mycobacterium tuberculosis direct test in a public health laboratory: test performance and impact on clinical care. Chest. 2007;132:946-951.
89. Schluger NW, Rom WN. Current approaches to the diagnosis of active pulmonary tuberculosis. Am J Respir Crit Care Med. 1994;149:264-267. (Pubitemid 24066130)
90. Cruciani M, Scarparo C, Malena M, Bosco O, Serpelloni G, Mengoli C. Meta-analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without solid media, for detection of mycobacteria. J Clin Microbiol. 2004;42:2321-2325. (Pubitemid 38637876)
91. Pai M, Minion J, Sohn H, Zwerling A, Perkins M. Novel and improved technologies for tuberculosis diagnosis: progress and challenges. Clin Chest Med. 2009;2009;30(4):701-716.
92. Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010;363(11):1005-1015.
93. Small PM, Pai M. Tuberculosis diagnosis-time for a game change [editorial]. N Engl J Med. 2010;363:1070-1071.
94. Centers for Disease Control and Prevention (CDC); American Thoracic Society. Update: adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection-United States, 2003. MMWR Morb Mortal Wkly Rep. 2003;52(31):735-739.
95. Centers for Disease Control and Prevention (CDC). Severe isoniazid-associated liver injuries among persons being treated for latent tuberculosis infection-United States, 2004-2008. MMWR Morb Mortal Wkly Rep. 2010;59:224-229.
96. Zierski M, Bek E, Long MW, Snider DE Jr. Short-course (6-month) cooperative tuberculosis study in Poland: results 30 months after completion of treatment. Am Rev Respir Dis. 1981;124:249-251. (Pubitemid 11003986)
97. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council. A controlled trial of a 2-month, 3-month, and 12-month regimens of chemotherapy for sputum smear-negative pulmonary tuberculosis: the results at 30 months. Am Rev Respir Dis. 1981;124:138-142.
98. Mitchison DA. Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months. Am Rev Respir Dis. 1993;147:1062-1063. (Pubitemid 23093839)
99. Benator D, Bhattacharya M, Bozeman L, et al. Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial. Lancet. 2002;360:528-534.
100. Francis J. Curry National Tuberculosis Center. http://www. nationaltbcenter.edu. Accessed February 22, 2011.
101. Heartland National Tuberculosis Center. http://www.heartlandntbc.org/. Accessed February 22, 2011.
102. New Jersey Medical School Global Tuberculosis Institute. http://www.umdnj.edu/globaltb/home.htm. Accessed February 22, 2011.
103. Southeastern National Tuberculosis Center. http://sntc.medicine.ufl. edu/. Accessed February 22, 2011.
104. Murdoch DM, Venter WD, Feldman C, Van Rie A. Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study. AIDS. 2008;22(5):601-610. (Pubitemid 351640593)
105. French MA, Lenzo N, John M, et al. Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med. 2000;1(2):107-115.
106. Narita M, Ashkin D, Hollender ES, Pitchenik AE. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med. 1998;158:157-161. (Pubitemid 28337174)
107. Wendel KA, Alwood KS, Gachuhi R, Chaisson RE, Bishai WR, Sterling TR. Paradoxical worsening of tuberculosis in HIV-infected persons. Chest. 2001;120:193-197. (Pubitemid 32744878)
108. Manabe YC, Campbell JD, Sydnor E, Moore RD. Immune reconstitution inflammatory syndrome: risk factors and treatment implications. J Acquir Immune Defic Syndr. 2007;46(4):456-462. (Pubitemid 350098697)
109. Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009;58(RR-4):1-207.
110. Shah NS, Pratt R, Armstrong L, Robison V, Castro KG, Cegielski JP. Extensively drug-resistant tuberculosis in the United States, 1993-2007. JAMA. 2008;300:2153-2160.
111. Kwon YS, Kim YH, Suh GY, et al. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis. Clin Infect Dis. 2008;47:496-502.
112. Kang MW, Kim HK, Choi YS, et al. Surgical treatment for multidrug-resistant and extensive drug-resistant tuberculosis. Ann Thorac Surg. 2010;89:1597-1602.
113. Weis SE, Slocum PC, Blais FX, et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med. 1994;330:1179-1184. (Pubitemid 24121986)
114. Chaulk CP, Kazandjian VA. Directly observed therapy for treatment completion of pulmonary tuberculosis: consensus statement of the Public Health Tuberculosis Guidelines Panel [published correction appears in JAMA. 1998;280(2):134]. JAMA. 1998;279(12):943-948. (Pubitemid 28136084)
115. National Tuberculosis Controllers Association; Centers for Disease Controll and Prevention (CDC). Guidelines for the investigation of contacts of persons with infectious tuberculosis: recommendations from the National Tuberculosis Controllers Association and CDC. MMWR Recomm Rep. 2005;54(RR-15):1-47.